Mater Misericordiae Limited

Brisbane 4101

2 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Transitional Cell, Metabolic Dysfunction-Associated Steatotic Liver Disease, Neoplasm Metastasis, Ulcerative Colitis, Urinary Bladder Neoplasms

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling